Register entry

Contipro a.s.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
2
Live patents
0
Countries
1
Base
Czechia
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Contipro a.s.Dolni Dobrouc 401, Dolni Dobrouc, 56102, Czech Republic (CZE)Active ingredient (API) manufacture3006440700360552830
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 bulk ingredient. By marketing category: BULK INGREDIENT 2.

Dosage formNDCs
powder2
RouteNDCs
Labeller name on the listingNDCs
contipro a.s.2
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
-Hyaluronate sodiumpowder40004-001BULK INGREDIENT
-Sodium Hyaluronate type IIpowder40004-002BULK INGREDIENT
Compare

Comparable companies in Czechia

Enquiry

Common questions

Is Contipro a.s. FDA approved?
Contipro a.s. holds 1 FDA-registered establishment in Czechia. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Contipro a.s.'s drugs manufactured?
The FDA register lists Dolni Dobrouc. Registered operations: active ingredient (API) manufacture.
What drugs does Contipro a.s. make?
2 products are listed under Contipro a.s. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.